Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Dienogest vs Dienogest/Estradiol Valerate on Endometrioma
NCT03789123Phase 4Unknown
- Sponsor
- Bağcılar Training and Research Hospital
- Start
- Jan 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of estradiol valerate + dienogest in endometriosis (5 arms), sponsored by Bağcılar Training and Research Hospital. Primary endpoint: Ovarian reserve at 24 months. Status: unknown.
02
Drugs
estradiol valerate + dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03789123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789123.